CATALYST PHARMACEUTICA
23.92
08-November-24 11:21:57
15 minutes delayed
Stocks
+0.67
+2.88%
Today's range
23.37 - 23.95
ISIN
N/A
Source
NASDAQ
-
10 Jan 2022 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences
04 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
15 Nov 2021 16:15:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results
09 Nov 2021 16:15:04 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
25 Oct 2021 08:03:00 By Nasdaq GlobeNewswire
-
30 Sep 2021 12:08:12 By Nasdaq GlobeNewswire
-
17 Sep 2021 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
10 Sep 2021 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations
16 Aug 2021 08:03:00 By Nasdaq GlobeNewswire
-
09 Aug 2021 16:39:16 By Nasdaq GlobeNewswire
-
26 Jul 2021 08:03:00 By Nasdaq GlobeNewswire
-
19 Jul 2021 08:03:00 By Nasdaq GlobeNewswire
-
06 Jul 2021 08:03:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
29 Jun 2021 08:03:00 By Nasdaq GlobeNewswire
-
28 Jun 2021 16:30:00 By Nasdaq GlobeNewswire
-
28 Jun 2021 08:03:00 By Nasdaq GlobeNewswire
-
03 Jun 2021 13:20:00 By Nasdaq GlobeNewswire
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
19 May 2021 08:03:00 By Nasdaq GlobeNewswire